Effect of Omalizumab on Blood Basophil Counts in Patients with Chronic Idiopathic/Spontaneous Urticaria

J Invest Dermatol. 2017 Apr;137(4):958-961. doi: 10.1016/j.jid.2016.11.025. Epub 2016 Dec 6.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Allergic Agents / therapeutic use*
  • Basophils / physiology*
  • Chronic Disease
  • Humans
  • Leukocyte Count
  • Omalizumab / therapeutic use*
  • Prospective Studies
  • Urticaria / blood
  • Urticaria / drug therapy*
  • Urticaria / etiology

Substances

  • Anti-Allergic Agents
  • Omalizumab

Associated data

  • ClinicalTrials.gov/NCT01287117
  • ClinicalTrials.gov/NCT01292473
  • ClinicalTrials.gov/NCT01264939